Coeliac Disease
Coeliac disease is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine, causing various digestive issues and other health problems.
Celiac Disease: Amlitelimab Treatment Study
We are investigating whether amlitelimab can help adults with non-responsive celiac disease improve their symptoms and intestinal health while on a gluten-free diet. The study also examines the safety of this new treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a doctor-diagnosed celiac disease?
- Have you had gastrointestinal symptoms like diarrhea or abdominal pain related to gluten exposure in the last month?
- Are you currently taking any medications like ibuprofen or naproxen more than twice a week?
- Do you have any severe complications from celiac disease, like refractory celiac disease or enteropathy associated T-cell lymphoma?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Amlitelimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Campus Gasthuisberg Maag-, darm- en leverziekten
Heverlee, Belgium
Cliniques Universitaires Saint-Luc
Hépato-gastroentérologie
Sint-Stevens-Woluwe, Belgium
Vojenska Nemocnice Brno
Interni oddeleni
Brno, Czechia
Sponsor: Sanofi-Aventis Recherche & Developpement
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.